Dunn said hospitals in Utah have been "stable" until this week. The state dashboard reports a 27.3% increase in the seven-day average of COVID-19 hospitalizations, and a 35.3% jump in seven-day average cases in the ICU.
"The silver lining in this increase is that it's definitely not as steep," she said. "It's happening at a slower pace."
Dunn said the increase in cases could be from new Omicron subvariants and vaccination/booster shot immunity wearing off.
"We're starting to see that increase and with that, an increase in positivity," said Dunn. "So we're now seeing 25% to 30% positivity."
She said current positivity rates mirror similar peaks seen in early 2021 and beyond.
"The people-over-people method is up 625% since April 2," she explained. "The testing-over-testing method is up 850%."
On Fri, Jun 10, 2022 at 3:00 PM Larry wrote:
The breakthrough stems from the team's explorations in what's known as intracellular thermogenesis, an emerging field that centers on gauging temperature changes within cells. Advanced sensors have made such measurements possible, and the team is the first to apply it to the study of Alzheimer's disease, focusing their attention on one of the prime suspects in its onset known as amyloid-beta proteins.
The buildup of amyloid-beta proteins into toxic clumps is considered a key driver of the neurodegeneration associated with Alzheimer's disease, and they therefore receive considerable attention from scientists working to better understand the condition. The Cambridge team had been investigating links between intracellular thermogenesis and amyloid-beta aggregation, and these advanced new sensors provided the perfect tools to delve into the details.
"Thermogenesis has been associated with cellular stress, which may promote further aggregation," said Chyi Wei Chung, the study's first author. "We believe that when there's an imbalance in cells, like when the amyloid-beta concentration is slightly too high and it starts to accumulate, cellular temperatures increase."